Trodelvy: Injection for intravenous infusion

The FDA approved the drug Sacituzumab govitecan hziy for the treatment of unresectable locally advanced or metastatic triple-negative Breast Cancer (mTNBC) and locally advanced or metastatic urothelial cancer (mUC). Sacituzumab govitecan hziy is sold under the brand name of Trodelvy. The medicine Trodelvy is supplied in single-dose vials of 180 mg for intravenous infusion. In India, Trodelvy price is reasonable, and one can find this medicine with several generic medicine suppliers. For more queries, call us at 1800-889-1064.

https://www.indianpharmanetwork.in/trodelvy-sacituzumab-govitecan-hziy/ Tweet